Living Longer with HIV: A New Battlefront Emerges
Thanks to the incredible success of antiretroviral therapy (ART), people living with HIV are enjoying longer, healthier lives. But here's where it gets complicated: this extended lifespan has unveiled a new challenge – Cardiovascular-Kidney-Metabolic (CKM) syndrome. This complex condition, still not fully understood in the context of HIV, poses a significant threat to the well-being of this population.
A Perfect Storm of Factors
CKM in people with HIV isn't just about one thing going wrong. It's a perfect storm fueled by chronic inflammation, intricate changes in how the body processes medications (pharmacokinetics), metabolic side effects of ART, and an imbalance in gut bacteria (dysbiosis). Managing CKM often means adding more medications to the mix, increasing the risk of dangerous drug interactions and unwanted side effects. This makes CKM a critical priority for clinical pharmacology research.
Unraveling the Mystery: A Call to Action
A recent perspective published in Clinical Pharmacology & Therapeutics (https://ascpt.onlinelibrary.wiley.com/doi/full/10.1002/cpt.70164) highlights the urgent need for more research into CKM in people with HIV. We need to understand the unique interplay of factors contributing to this syndrome and develop tailored treatment strategies that minimize risks and maximize quality of life.
Staying Informed, Taking Action
The fight against CKM in HIV requires a collective effort. Stay informed about the latest developments through resources like the EATG (https://www.eatg.org/). Their website offers valuable updates on:
- Quality of life and comorbidities: https://www.eatg.org/hiv-news/new-data-from-eacs-2025-on-quality-of-life-and-comorbidities-in-people-with-hiv/
- Long-acting HIV treatments and related health issues: https://www.eatg.org/hiv-news/catie-treatmentupdate-256-long-acting-hiv-treatment-hepatitis-c-sleep/
- Emerging research on cancer risk prediction: https://www.eatg.org/hiv-news/new-study-identifies-immune-markers-that-may-predict-cancer-development-in-people-living-with-hiv/
Get Involved: Your Voice Matters
Are you living with HIV or connected to this community? Your experience is invaluable. Consider joining the EATG (https://www.eatg.org/become-a-member/) or supporting their work (https://www.eatg.org/support-us/). Subscribe to their newsletter (http://eepurl.com/duRu4D) and HIV & Co-infections Bulletin (http://eepurl.com/b582Sn) to stay connected and informed.
A Controversial Question:
As we delve deeper into CKM research, we must ask: Are current ART regimens contributing to the rise of CKM, and if so, how can we balance the benefits of viral suppression with the potential long-term risks? Let's spark a conversation in the comments – what are your thoughts on this complex issue?
